Recent News

• 06.02.2025 - Calidi Biotherapeutics Presents Systemic Oncolytic Platform with CD55-Enhanced Expression and IL-15 Superagonist Payload at ASCO Annual Meeting
• 05.19.2025 - Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights

Recent Filings

• 05.23.2025 - DEF 14A Other definitive proxy statements
• 05.23.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.14.2025 - EX-99.1 EX-99.1
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2025 - 8-K Current report
• 05.12.2025 - PRE 14A Other preliminary proxy statements
• 05.02.2025 - 8-K Current report
• 04.25.2025 - 3 Initial statement of beneficial ownership of securities
• 04.25.2025 - 4 Statement of changes in beneficial ownership of securities